Kindred Biosciences to Present at 7th Annual LD Micro Invitational

SAN FRANCISCO, May 24, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise Bevers, Co-Founder and COO, will be presenting and hosting one-on-one investor meetings at the 7^th Annual LD Micro Invitational in Los Angeles, CA on Tuesday, June 6, 2017 at 1:30 PM PST. The conference will be held at the Luxe Sunset Bel Air Hotel.

Following the presentation, the slide deck will be available for 30 days on the Company's website: http://kindredbio.com/investor-relations/events.

About Kindred Biosciences, Inc. 

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets.  Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.  The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses.  The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

Contact

Russell Radefeld
KindredBio
Russell.radefeld@kindredbio.com 
(650) 701-7904

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-7th-annual-ld-micro-invitational-300462801.html

SOURCE Kindred Biosciences, Inc.